Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.

Autor: Tomita, Toshihiko1 (AUTHOR), Fukui, Hirokazu1 (AUTHOR) hfukui@hyo-med.ac.jp, Morishita, Daisuke1 (AUTHOR), Mori, Sumire1 (AUTHOR), Oshima, Tadayuki1 (AUTHOR), Shinzaki, Shinichiro1 (AUTHOR), Miwa, Hiroto1 (AUTHOR)
Zdroj: Journal of Clinical Medicine. Dec2022, Vol. 11 Issue 23, p6882. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje